Importantly, expression of the major AD risk gene APOE varies across cell types, being reduced in oligodendrocyte progenitors and selected astrocyte subsets but strongly upregulated in a disease-associated microglial state (Grubman et al., 2019). This evidence concerns the gene APOE and Alzheimer disease.